← Leaderboards
Ian Michael McGowan
University Of California Los Angeles
$58,156,521
Attributed
$87,540,556
Total exposure
15
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $28.5M · FY2005–18$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$98,647,601 · 16
By mechanism
UM1$57,783,806 · 1
U19$30,024,097 · 12
R01$7,618,040 · 2
U01$3,221,658 · 1
Top collaborators
- Sharon L Hillier3 shared
- Saye Khoo2 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Anne-Marie Corner$3,144,364
- Wesley Yin$1,285,228
- Steven Grant Deeks$52,964,444
- Peter A Anton$8,396,612
Others in their field
Top investigators on “Microbicide”
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$236,162,238
- Sten H Vermund · University Of Alabama At Birmingham$126,807,672
- Constance Ann Benson · University Of California, San Diego$121,929,528
- Zvavahera Mike Chirenje · University Of California, San Francisco$117,489,864
- Daniel R Kuritzkes · Brigham And Women'S Hospital$110,608,809
- Elizabeth Renata Brown · Fred Hutchinson Cancer Center$66,500,302
Research focus
MicrobicideRectalRectal MicrobicideProgramsBaseHiv InfectionsPreventionTransmission ProcessDoseUniversitiesClinical TrialsSiteSafetyAnusAids PreventionPharmaceutical PreparationsVaginaPre-ClinicalWomanSamplingTissuesHiv-1Anti-Retroviral AgentsPhase I Clinical Trials
Grant awards (58)
IND-enabling critical path for a tenofovir analog enema$307,103
U19 · FY2018 · AI · contact PI
IND-enabling critical path for a tenofovir analog enema$667,819
U19 · FY2017 · AI · contact PI
Development of a urine-based point-of-care test for adherence to antiretroviral drugs$399,090
R01 · FY2017 · AI · contact PI
Project 3: PREVENT: A first-in-human clinical trial of Griffithsin, an HIV entry$317,272
U19 · FY2017 · AI · contact PI
Regulatory Core$226,945
U19 · FY2017 · AI · contact PI
Core D: PREVENT Program Regulatory Affairs Core$182,834
U19 · FY2017 · AI · contact PI
Leadership and Operations Center (LOC): Microbicide Trials Network$15,759,391
UM1 · FY2016 · AI
IND-enabling critical path for a tenofovir analog enema$828,981
U19 · FY2016 · AI · contact PI
Development of a urine-based point-of-care test for adherence to antiretroviral drugs$585,175
R01 · FY2016 · AI · contact PI
Project 3: PREVENT: A first-in-human clinical trial of Griffithsin, an HIV entry$526,610
U19 · FY2016 · AI · contact PI
Regulatory Core$303,223
U19 · FY2016 · AI · contact PI
Core D: PREVENT Program Regulatory Affairs Core$206,892
U19 · FY2016 · AI · contact PI
Leadership and Operations Center (LOC): Microbicide Trials Network$27,707,809
UM1 · FY2015 · AI
Project 3: PREVENT: A first-in-human clinical trial of Griffithsin, an HIV entry$328,566
U19 · FY2015 · AI · contact PI
Core D: PREVENT Program Regulatory Affairs Core$249,912
U19 · FY2015 · AI · contact PI
Regulatory Core$222,808
U19 · FY2015 · AI · contact PI
Leadership and Operations Center (LOC): Microbicide Trials Network$14,316,606
UM1 · FY2014 · AI
Project 3: PREVENT: A first-in-human clinical trial of Griffithsin, an HIV entry$442,627
U19 · FY2014 · AI · contact PI
Regulatory Core$270,660
U19 · FY2014 · AI · contact PI
Core D: PREVENT Program Regulatory Affairs Core$153,669
U19 · FY2014 · AI · contact PI
Combination HIV Antiretroviral Rectal Microbicide Program$1,949,838
U19 · FY2013 · AI · contact PI
Exploratory Human Trials of Combination Rectal Microbicides$800,327
U19 · FY2013 · AI · contact PI
Administrative Core$188,740
U19 · FY2013 · AI · contact PI
Combination HIV Antiretroviral Rectal Microbicide Program$64,603
U19 · FY2013 · AI · contact PI
Combination HIV Antiretroviral Rectal Microbicide Program$2,169,798
U19 · FY2012 · AI · contact PI
Microbicide Safety and Acceptability in Young Men$1,617,391
R01 · FY2012 · HD · contact PI
Exploratory Human Trials of Combination Rectal Microbicides$1,437,297
U19 · FY2012 · AI · contact PI
Administrative Core$298,882
U19 · FY2012 · AI · contact PI
Combination HIV Antiretroviral Rectal Microbicide Program$2,396,779
U19 · FY2011 · AI · contact PI
Microbicide Safety and Acceptability in Young Men$1,658,809
R01 · FY2011 · HD · contact PI
Exploratory Human Trials of Combination Rectal Microbicides$815,201
U19 · FY2011 · AI · contact PI
Administrative Core$227,906
U19 · FY2011 · AI · contact PI
Combination HIV Antiretroviral Rectal Microbicide Program$2,285,314
U19 · FY2010 · AI · contact PI
Microbicide Safety and Acceptability in Young Men$1,669,891
R01 · FY2010 · HD · contact PI
Exploratory Human Trials of Combination Rectal Microbicides$823,265
U19 · FY2010 · AI · contact PI
Administrative Core$213,695
U19 · FY2010 · AI · contact PI
Combination HIV Antiretroviral Rectal Microbicide Program$2,240,713
U19 · FY2009 · AI · contact PI
Microbicide Safety and Acceptability in Young Men$1,687,684
R01 · FY2009 · HD · contact PI
Exploratory Human Trials of Combination Rectal Microbicides$794,367
U19 · FY2009 · AI · contact PI
Aptamer Microbicide Development Program (MDP)$598,613
U01 · FY2009 · AI · contact PI
Exploratory human trials of rectal microbicides$502,442
U19 · FY2009 · AI · contact PI
Administrative Core$212,548
U19 · FY2009 · AI · contact PI
Preclinical evaluation of HIV rectal microbicides$1,621,723
U19 · FY2008 · AI · contact PI
Aptamer Microbicide Development Program (MDP)$634,364
U01 · FY2008 · AI · contact PI
Core--Regulatory compliance and human subjects safety$319,321
U19 · FY2008 · AI · contact PI
Preclinical evaluation of HIV rectal microbicides$1,518,897
U19 · FY2007 · AI · contact PI
Aptamer Microbicide Development Program (MDP)$525,637
U01 · FY2007 · AI · contact PI
Core--Regulatory compliance and human subjects safety$299,084
U19 · FY2007 · AI · contact PI
Aptamer Microbicide Development Program (MDP)$146,928
U01 · FY2007 · AI · contact PI
Preclinical evaluation of HIV rectal microbicides$1,060,031
U19 · FY2006 · AI · contact PI
Aptamer Microbicide Development Program (MDP)$640,181
U01 · FY2006 · AI · contact PI
Regulatory compliance and human subjects safety$208,719
U19 · FY2006 · AI · contact PI
Core B - Regulatory Compliance and Subject Safety$42,838
U19 · FY2006 · AI · contact PI
Preclinical evaluation of HIV rectal microbicides$976,478
U19 · FY2005 · AI
Aptamer Microbicide Development Program (MDP)$675,935
U01 · FY2005 · AI
Regulatory compliance and human subjects safety$192,268
U19 · FY2005 · AI
Preclinical evaluation of HIV rectal microbicides$941,685
U19 · FY2004 · AI
Regulatory compliance and human subjects safety$185,417
U19 · FY2004 · AI